Don't Just Read the News, Understand It.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Israel-Iran Conflict
Iran Politics
Donald Trump
Airstrike
Heatwaves
US Foreign Policy
Military
Middle East Politics
Artificial Intelligence
Social Media
Democratic Party
Republican Party
Cardiovascular News image

News from Cardiovascular News

We’ve assigned a rating of Unknown factuality to Cardiovascular News. You can read more about how we’ve determined Cardiovascular News’s credibility and reliability as a news source here: https://ground.news/rating-system.

Information about Cardiovascular News

Where is Cardiovascular News located?Cardiovascular News's Website

Media Bias Ratings

Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.

Factuality

Learn more about  Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about  Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Cardiovascular News News

Oral Semaglutide Significantly Improves Cardiovascular Outcomes in Individuals with Type 2 Diabetes
Diabetes · Hillsboro

Oral Semaglutide Significantly Improves Cardiovascular Outcomes in Individuals with Type 2 Diabetes

100% Center coverage: 15 sources
Oral formulation demonstrates comparable cardiovascular benefits to injectable GLP-1sSee the Story
UK Regulator Overhauls Medical Device Regulation
Regulation · United Kingdom

UK Regulator Overhauls Medical Device Regulation

100% Center coverage: 1 sources
Major changes to medical device regulations in the UK have come into force with an overhaul of post-market surveillance requirements.See the Story
Corvia Medical closes $55 million funding round to complete confirmatory trial and pursue FDA approval of Corvia Atrial Shunt

Corvia Medical closes $55 million funding round to complete confirmatory trial and pursue FDA approval of Corvia Atrial Shunt

100% Center coverage: 1 sources
Existing investors provide funding to finish international RESPONDER-HF trialSee the Story

Enrolment milestone met in CORCINCH-HF pivotal trial - Cardiovascular News

AccuCinch Ancora Heart has announced that it has reached the first enrolment milestone in the CORCINCH-HF pivotal trial evaluating the AccuCinch transcatheter left ventricular restoration system in patients with heart failure with reduced ejection fraction (HFrEF). Six-month follow-up data on these 250 patients will support the company’s premarket approval (PMA) submission to the US Food and Drug Administration (FDA). The AccuCinch system is an …New York State · New YorkRead Article

Penumbra's Revolutionary PE Treatment Trial Hits 100-Patient Mark, Results Could Transform Blood Clot Care

First-of-its-kind RCT evaluates computer-assisted thrombectomy vs. standard care in 100 PE patients. Trial completed ahead of schedule. See potential impact.See the Story

Study intensifies call for randomised trial in patients with bicuspid aortic stenosis - Cardiovascular News

Thomas Cuisset The results of a retrospective analysis should act as a “word of caution” against the liberal use of transcatheter aortic valve implantation (TAVI) in younger patients with bicuspid aortic valve anatomy. These were the comments of Thomas Cuisset (CHU Timone, Marseille, France), speaking at EuroPCR 2025 (20–23 May, Paris, France), where the results of the analysis which used propensity score matching to compare outcomes after TAVI …Marseille · MarseilleRead Article

Stroke rates diverge among TAVI and surgery patients at five years in pragmatic trial - Cardiovascular News

William Toff Long-term results of the UK TAVI trial, a pragmatic trial comparing transcatheter aortic valve implantation (TAVI) to surgical aortic valve replacement (SAVR) point to comparable rates of mortality, myocardial infarction (MI), endocarditis and reintervention between the two strategies at five years, but a higher incidence of stroke among TAVI patients. “Most of the previously published major TAVI trials have focused on specific valv…Leicester, United Kingdom · LeicesterRead Article

Ceryx Medical to develop physiologically responsive pacemaker following funding boost - Cardiovascular News

Ceryx Medical has announced the successful closure of a new funding round, bringing the company’s total raised to US $15 million, with the new investment intended to accelerate development of a permanent, physiologically responsive pacemaker designed to provide long-term support for patients with chronic heart failure. The investment marks a major milestone in Ceryx’s mission to revolutionise cardiac care with intelligent, adaptive pacing techno…Bristol, England · BristolRead Article

Prevencio granted patents to protect proprietary coronary artery disease blood test platform - Cardiovascular News

Prevencio has been granted patents for its HART CADhs test in the USA—the second US patent for this novel test—as well as the EU and Japan. The patents protect Prevencio’s proprietary methods and algorithms for detecting obstructive coronary artery disease (CAD) using a multi-protein, artificial intelligence (AI)-driven blood test platform. The newly issued patents strengthen Prevencio’s intellectual property portfolio and support its long-term …European Union · United StatesRead Article

Enrolment completed in ATHENS-HF first-in-human study of Adona interatrial atrial shunt - Cardiovascular News

Gagan Singh (left) was present at the initial cases of Adona Medical’s adjustable interatrial shunt for heart failure, conducted in the Republic of Georgia led by George Khabeishvili and supported by Edris Aman and the Adona Medical team Adona Medical has announced the completion of enrolment in the ATHENS-HF first-in-human study, studying the company’s chronically-adjustable interatrial shunt with integrated bi-atrial pressure monitoring. The d…New York State · New YorkRead Article

MedHub-AI and Terumo partner to market AI-based FFR in Japan

100% Center coverage: 1 sources
TEL AVIV, Israel, June 17, 2025 /PRNewswire/ -- MedHub-AI, pioneer of AI-based FFR "AutocathFFR" software, today announced a distribution agreement with Terumo Corporation to bring AutocathFFR®, its groundbreaking AI-powered Software as a Medical Device (SaMD), to the Japanese market. This…Artificial Intelligence · JapanSee the Story

Breaking News Topics Related to Cardiovascular News

United Kingdom icon

United Kingdom

New York State icon

New York State

France icon

France

Artificial Intelligence icon

Artificial Intelligence

United States icon

United States

Medical icon

Medical

News
For You
SearchBlindspotLocal